![Motoo Watanabe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Motoo Watanabe
Directeur Technique/Scientifique/R&D chez
Megakaryon Corp.
Profil
Motoo Watanabe was the founder of Celaid Therapeutics, Inc., founded in 2020, and held the title of Chairman & Chief Scientific Officer from 2020 to 2023.
Dr. Watanabe currently holds the position of Chief Technology Officer at Megakaryon Corp.
Dr. Watanabe completed an undergraduate degree at the University of Tokyo in 1974 and a doctorate at the University of Tokyo in 1988.
Postes actifs de Motoo Watanabe
| Sociétés | Poste | Début |
|---|---|---|
Megakaryon Corp.
 Megakaryon Corp. Medical/Nursing ServicesHealth Services Operates an pluripotent stem cells research laboratory | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Motoo Watanabe
| Sociétés | Poste | Fin |
|---|---|---|
Celaid Therapeutics, Inc.
 Celaid Therapeutics, Inc. BiotechnologyHealth Technology Develops cell therapies for treatment of cancer | Fondateur | 01/12/2023 |
Formation de Motoo Watanabe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Megakaryon Corp.
Megakaryon Corp. Medical/Nursing ServicesHealth Services Operates an pluripotent stem cells research laboratory | Health Services |
Celaid Therapeutics, Inc.
Celaid Therapeutics, Inc. BiotechnologyHealth Technology Develops cell therapies for treatment of cancer | Health Technology |
Choisissez Zonebourse 
